Shares of Parnell Pharmaceuticals Holdings Ltd (OTCMKTS:PARNF – Get Free Report) shot up 37.5% on Thursday . The company traded as high as $0.19 and last traded at $0.17. 10,000 shares were traded during mid-day trading, a decline of 53% from the average session volume of 21,500 shares. The stock had previously closed at $0.12.
Parnell Pharmaceuticals Stock Performance
About Parnell Pharmaceuticals
Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal – U.S., Production Animal – Rest of World, and Manufacturing Operations.
Further Reading
- Five stocks we like better than Parnell Pharmaceuticals
- Stock Sentiment Analysis: How it Works
- Bloom Energy: Powering the Future With Decentralized Energy
- How to Use the MarketBeat Excel Dividend Calculator
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Parnell Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parnell Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
